138 related articles for article (PubMed ID: 26708644)
1. Diet in children with phenylketonuria and risk of cardiovascular disease: A narrative overview.
Verduci E; Banderali G; Moretti F; Lassandro C; Cefalo G; Radaelli G; Salvatici E; Giovannini M
Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):171-7. PubMed ID: 26708644
[TBL] [Abstract][Full Text] [Related]
2. Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.
Couce ML; Vitoria I; Aldámiz-Echevarría L; Fernández-Marmiesse A; Roca I; Llarena M; Sánchez-Pintos P; Leis R; Hermida A
Orphanet J Rare Dis; 2016 Sep; 11(1):123. PubMed ID: 27612877
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma adiponectin concentrations in poorly controlled patients with phenylketonuria normalize with a strict diet: evidence for catecholamine-mediated adiponectin regulation and a complex effect of phenylketonuria diet on atherogenesis risk factors.
Schulpis KH; Papassotiriou I; Tsakiris S; Vounatsou M; Chrousos GP
Metabolism; 2005 Oct; 54(10):1350-5. PubMed ID: 16154435
[TBL] [Abstract][Full Text] [Related]
4. Free asymmetric dimethylarginine (ADMA) is low in children and adolescents with classical phenylketonuria (PKU).
Huemer M; Simma B; Mayr D; Möslinger D; Mühl A; Schmid I; Ulmer H; Bodamer OA
J Inherit Metab Dis; 2012 Sep; 35(5):817-21. PubMed ID: 22290024
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric dimethylarginine as a potential biomarker for management and follow-up of phenylketonuria.
Andrade F; Villate O; Couce ML; Bueno MA; Alcalde C; de Las Heras J; Ceberio L; Núñez-Marcos S; Nambo PS; Aldámiz-Echevarría L
Eur J Pediatr; 2019 Jun; 178(6):903-911. PubMed ID: 30941500
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethylarginine in children with homocystinuria or phenylketonuria.
Kanzelmeyer N; Tsikas D; Chobanyan-Jürgens K; Beckmann B; Vaske B; Illsinger S; Das AM; Lücke T
Amino Acids; 2012 May; 42(5):1765-72. PubMed ID: 21472412
[TBL] [Abstract][Full Text] [Related]
7. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet.
Schulpis KH; Karakonstantakis T; Bartzeliotou A; Karikas GA; Papassotiriou I
Clin Nutr; 2004 Jun; 23(3):401-7. PubMed ID: 15158304
[TBL] [Abstract][Full Text] [Related]
8. Dietary glycemic index, glycemic load and metabolic profile in children with phenylketonuria.
Moretti F; Pellegrini N; Salvatici E; Rovelli V; Banderali G; Radaelli G; Scazzina F; Giovannini M; Verduci E
Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):176-182. PubMed ID: 28081989
[TBL] [Abstract][Full Text] [Related]
9. Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet.
Schulpis KH; Bartzeliotou A; Tsakiris S; Gounaris A; Papassotiriou I
Eur J Clin Nutr; 2007 Jun; 61(6):803-8. PubMed ID: 17203019
[TBL] [Abstract][Full Text] [Related]
10. Plasma cholesterol in adults with phenylketonuria.
Williams RA; Hooper AJ; Bell DA; Mamotte CD; Burnett JR
Pathology; 2015 Feb; 47(2):134-7. PubMed ID: 25551302
[TBL] [Abstract][Full Text] [Related]
11. Influence of phenylketonuria's diet on dimethylated arginines and methylation cycle.
Andrade F; López-Suárez O; Llarena M; Couce ML; Aldámiz-Echevarría L
Medicine (Baltimore); 2017 Jul; 96(27):e7392. PubMed ID: 28682891
[TBL] [Abstract][Full Text] [Related]
12. Optimal serum phenylalanine for adult patients with phenylketonuria.
Okano Y; Nagasaka H
Mol Genet Metab; 2013 Dec; 110(4):424-30. PubMed ID: 24094552
[TBL] [Abstract][Full Text] [Related]
13. Is the Phenylalanine-Restricted Diet a Risk Factor for Overweight or Obesity in Patients with Phenylketonuria (PKU)? A Systematic Review and Meta-Analysis.
Rodrigues C; Pinto A; Faria A; Teixeira D; van Wegberg AMJ; Ahring K; Feillet F; Calhau C; MacDonald A; Moreira-Rosário A; Rocha JC
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684443
[TBL] [Abstract][Full Text] [Related]
14. Comparison of atherogenic risk factors among poorly controlled and well-controlled adolescent phenylketonuria patients.
Gündüz M; Çakar S; Kuyum P; Makay B; Arslan N
Cardiol Young; 2016 Jun; 26(5):901-8. PubMed ID: 26278115
[TBL] [Abstract][Full Text] [Related]
15. Elevated plasma adiponectin and decreased plasma homocysteine and asymmetric dimethylarginine in children with type 1 diabetes.
Heilman K; Zilmer M; Zilmer K; Kool P; Tillmann V
Scand J Clin Lab Invest; 2009; 69(1):85-91. PubMed ID: 18830896
[TBL] [Abstract][Full Text] [Related]
16. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
Ozcan O; Cakir E; Yaman H; Akgul EO; Erturk K; Beyhan Z; Bilgi C; Erbil MK
Clin Endocrinol (Oxf); 2005 Aug; 63(2):203-6. PubMed ID: 16060915
[TBL] [Abstract][Full Text] [Related]
17. Effect of diet on plasma total antioxidant status in phenylketonuric patients.
Schulpis KH; Tsakiris S; Karikas GA; Moukas M; Behrakis P
Eur J Clin Nutr; 2003 Feb; 57(2):383-7. PubMed ID: 12571675
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome in children and adolescents with phenylketonuria.
Kanufre VC; Soares RD; Alves MR; Aguiar MJ; Starling AL; Norton RC
J Pediatr (Rio J); 2015; 91(1):98-103. PubMed ID: 25458873
[TBL] [Abstract][Full Text] [Related]
19. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
20. Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation.
Cannet C; Pilotto A; Rocha JC; Schäfer H; Spraul M; Berg D; Nawroth P; Kasperk C; Gramer G; Haas D; Piel D; Kölker S; Hoffmann G; Freisinger P; Trefz F
Orphanet J Rare Dis; 2020 Feb; 15(1):61. PubMed ID: 32106880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
